Lung Injury: Clinical Trials

42 trials for Lung Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

42 completed. 42 Phase 3, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 342Completed 42
Phase 29Completed 9

Follow Lung Injury: new trials by email Literature Review of Lung Injury trials Research Report on Lung Injury

Trials (filtered) newest first · largest first

All 42 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration Syndrome
Budesonide, Normal Saline - Meconium Aspiration Syndrome
Phase 3CompletedKhyber Teaching Hospital602025-11-282026-08-13
Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury
Heparin, Normal Saline - Smoke Inhalation Injury, Acute Lung Injury
Phase 3CompletedAin Shams University882023-06-012024-12-12
Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19
Tigerase® and best available care, Best available care - COVID-19, Coronavirus Disease 2019
Phase 3CompletedAO GENERIUM1002020-06-012020-10-14
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
Aviptadil by intravenous infusion + standard of care, Normal Saline Infusion + standard of care - Critical COVID-19 With Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
Phase 2 / Phase 3CompletedAPR Applied Pharma Research s.a.2032020-05-152023-07-24
Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine
Hydroxychloroquine, Placebo oral tablet - COVID-19
Phase 3CompletedAdrian Hernandez13602020-04-222021-10-12
Treatment of COVID-19 Patients With Anti-interleukin Drugs
Usual Care, Anakinra, Siltuximab - COVID-19
Phase 3CompletedUniversity Hospital, Ghent3422020-04-032023-03-14
Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
Mid frequency ventilation, Standard frequency ventilation - Ventilator-Induced Lung Injury, Respiratory Distress Syndrome
Phase 2 / Phase 3CompletedUniversity of Alabama at Birmingham602017-08-022024-10-15
A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus
Palivizumab - Respiratory Syncytial Virus (RSV)
Phase 3CompletedAbbVie502016-11-092018-03-13
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
L-citrulline, Placebo - Acute Lung Injury
Phase 3CompletedAsklepion Pharmaceuticals, LLC1892016-08-012023-02-23
Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
Weekly INH / RRT given by DOT - Silicosis, Tuberculosis
Phase 3CompletedHuashan Hospital5662015-03-012020-06-30
The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure
Dexmedetomidine, Propofol - Sepsis, Delirium
Phase 3CompletedVanderbilt University Medical Center4382013-05-152021-06-07
Pragmatic, Randomized Optimal Platelet and Plasma Ratios
1:1:1 Blood Transfusion Ratio, 1:1:2 Blood Transfusion Ratio - Trauma
Phase 3CompletedThe University of Texas Health Science Center, Houston6802012-08-012019-02-08
Vitamin D Supplementation for Extremely Preterm Infants
Cholecalciferol, Placebo - Vitamin D Deficiency, Preterm Infants
Phase 2 / Phase 3CompletedUniversity of Alabama at Birmingham1002012-06-012017-02-10
Oral Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia in Preterm Infants
Vitamin A - Bronchopulmonary Dysplasia (BPD), Prematurity
Phase 3CompletedErhan Calisici2092012-03-012026-05-11
Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy
Goal-directed therapy, Restrictive fluid therapy - Complication, Postoperative
Phase 3CompletedUniversity Hospital, Geneva4002012-01-012019-09-12
Hydrocortisone for BPD
Hydrocortisone, Placebo - Infant, Newborn, Infant, Small for Gestational Age
Phase 3CompletedNICHD Neonatal Research Network8002011-08-112025-02-27
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
Nitric Oxide, respiratory support - Pulmonary Disease
Phase 2 / Phase 3CompletedFudan University4002011-05-012013-01-28
Clinical Effect of the Association of Noninvasive Ventilation and High Flow Nasal Oxygen Therapy in Resuscitation of Patients With Acute Lung Injury (FLORALI Study)
O2 conventional, O2-HFN : high flow nasal oxygen therapy, O2-HFN/NPPV : association of high flow nasal oxygen therapy and non invasive positive pressure ventilation - Acute Lung Injury, Acute Respiratory Failure
Phase 2 / Phase 3CompletedPoitiers University Hospital3132011-03-012016-10-11
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
Calfactant, Air placebo - Acute Lung Injury
Phase 2 / Phase 3CompletedMilton S. Hershey Medical Center432010-06-012018-03-16
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
Budesonide - Bronchopulmonary Dysplasia
Phase 3CompletedUniversity Children's Hospital Tuebingen8632010-04-012016-07-06

Showing 20 of 42. Sign in to see all of them.

Narrower conditions

Bronchopulmonary Dysplasia (24)  ·  Acute Lung Injury (14)  ·  Premature Birth (13)  ·  Respiratory Distress Syndrome (10)  ·  Lung Diseases (6)  ·  COVID-19 (4)  ·  Respiratory Insufficiency (4)  ·  Coronavirus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Coronaviridae Infections (2)  ·  Heart Defects, Congenital (2)  ·  Hyaline Membrane Disease (2)  ·  Infant, Newborn, Diseases (2)  ·  Retinopathy of Prematurity (2)

Broader conditions

Respiratory Tract Diseases (39)  ·  Lung Diseases (36)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (27)  ·  Infant, Premature, Diseases (24)  ·  Infant, Newborn, Diseases (23)  ·  Ventilator-Induced Lung Injury (23)  ·  Female Urogenital Diseases and Pregnancy Complications (15)  ·  Urogenital Diseases (15)  ·  Pregnancy Complications (14)  ·  Respiration Disorders (14)  ·  Obstetric Labor Complications (13)  ·  Obstetric Labor, Premature (13)  ·  Infections (7)  ·  Pathological Conditions, Signs and Symptoms (7)

Interventions

Endothelium-Dependent Relaxing Factors (3)  ·  Nitric Oxide (3)  ·  Budesonide (2)  ·  Continuous Positive Airway Pressure (2)  ·  Hydrocortisone (2)  ·  Palivizumab (2)  ·  Saline Solution (2)  ·  Standard of Care (2)  ·  calfactant (2)  ·  salicylhydroxamic acid (2)  ·  Air (1)  ·  Beclomethasone (1)  ·  Breath Holding (1)  ·  Cholecalciferol (1)  ·  Citrulline (1)

Sponsors

NICHD Neonatal Research Network (4)  ·  National Heart, Lung, and Blood Institute (NHLBI) (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Mallinckrodt (2)  ·  McMaster University (2)  ·  Roberta Ballard (2)  ·  University of Alabama at Birmingham (2)  ·  AO GENERIUM (1)  ·  APR Applied Pharma Research s.a. (1)  ·  AbbVie (1)  ·  Abbott (1)  ·  Adrian Hernandez (1)  ·  Ain Shams University (1)  ·  Asklepion Pharmaceuticals, LLC (1)  ·  Centre Leon Berard (1)

Countries

United States (22)  ·  Canada (6)  ·  France (6)  ·  Belgium (3)  ·  Netherlands (3)  ·  Austria (2)  ·  China (2)  ·  Germany (2)  ·  Israel (2)  ·  Russia (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Finland (1)

Top investigators

Seetha Shankaran, MD (4)  ·  Barbara J. Stoll, MD (3)  ·  Aaron Chiu, MD (2)  ·  Abhik Das, PhD (2)  ·  Avroy A. Fanaroff, MD (2)  ·  Bradley Yoder, MD (2)  ·  Charles R. Bauer, MD (2)  ·  David K. Stevenson, MD (2)  ·  Edward F. Donovan, MD (2)  ·  Haresh Kirpalani, MD, MSc (2)  ·  James A. Lemons, MD (2)  ·  Jon E. Tyson, MD MPH (2)  ·  Richard A. Ehrenkranz, MD (2)  ·  Roberta A Ballard, MD (2)  ·  Robin S Roberts, MTech (2)

Results publications

PMID 10400143, PMID 10545589, PMID 15767942, PMID 16014597, PMID 16651303, PMID 16870913, PMID 16870914, PMID 16939737, PMID 18245420, PMID 19117884, PMID 19841125, PMID 19841128, PMID 20138299, PMID 20405117, PMID 20472937, PMID 20472939, PMID 20587676, PMID 22307571, PMID 22371462, PMID 22738947, PMID 22943074, PMID 23268664, PMID 23944299, PMID 24335442, PMID 24388320, PMID 24725582, PMID 24876196, PMID 24996573, PMID 25425651, PMID 25554820, PMID 25647203, PMID 25981908, PMID 26162889, PMID 26431718, PMID 26465983, PMID 26500107, PMID 26916176, PMID 27079965, PMID 27344218, PMID 27440140, PMID 27583380, PMID 27650090, PMID 28100402, PMID 28279433, PMID 28384828, PMID 28600154, PMID 28731937, PMID 28930959, PMID 28973344, PMID 29275926

NIH funding

U10HD021364 (4), U10HD021373 (4), U10HD021385 (4), U10HD027851 (4), U10HD027853 (4), U10HD027856 (4), U10HD027880 (4), U10HD021397 (3), U10HD027871 (3), U10HD027904 (3), 2016 (2), M01RR000750 (2), M01RR008084 (2), U01HD019897 (2), U10HD021415 (2)